Page 18 - Sanket Koul

CDSCO extends COPP application deadline for pharma units to August 15

Pharma firms get time till August 15 to file COPP applications online via ONDLS as CDSCO addresses onboarding challenges and industry pleas

India needs tax breaks, startup push to lead global wellness tourism

KPMG-FHRAI report projects India's medical tourism to reach $58.2 bn by 2035, calls for tax incentives, global branding and startup support to drive growth

University of San Diego pauses plan to set up campus at Gujarat's GIFT city

San Diego varsity cites regulatory and cost barriers for pausing its GIFT City campus and will now expand in India through hybrid degrees, MoUs and online Master's programmes

University of Southampton opens India's first foreign varsity campus

The Gurugram campus marks the first operational foreign university in India under NEP 2020 reforms, offering UK-aligned UG and PG courses and enabling student mobility

Generic glut leads to numerous price actions on diabetes medications

While price revision lists by the National Pharmaceutical Pricing Authority (NPPA) include several diabetes drugs, combinations of empagliflozin have been prominently mentioned in past three months

Emcure enters distribution agreement with Sanofi for diabetes drugs

Emcure to distribute and promote Sanofi's oral anti-diabetic brands Amaryl and Cetapin in India, expanding access amid rising prevalence of uncontrolled diabetes

EQT-backed Indira IVF refiles DRHP through Sebi's confidential route

Indira IVF refiles DRHP after earlier withdrawal, as investor interest grows in India's ART sector; aims for Rs 3,500 crore IPO, joins peers like Swiggy and Meesho

Health Ministry clarifies no warning labels for samosa and jalebi

Union Health Ministry clarifies advisory urging awareness about fats and sugars in food, but no directive for warning labels on specific products like samosas or jalebis.

Tier 2 cities outpace metros in residential plot launches: PropEquity

Seven of the top 10 cities for residential plot launches were tier 2 locations, led by Indore, Nagpur and Surat, as investor interest shifts away from apartments

Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness

Flying high: Airport-adjacent micro mkts outpace city-wide price growth

Residential plot values in these corridors recorded a rise of 84 to 118 per cent, compared to a city-wide increase of 45 to 93 per cent

Sun Pharma launches Leqselvi in US after patent settlement with Incyte Corp

Sun Pharma will pay Incyte an upfront fee and royalties to market Leqselvi in the US for alopecia areata until patent expiry in FY26 following a litigation settlement

DLF sets sights on strong residential, commercial pipeline in medium term

DLF plans to achieve ambitious targets with a strong launch pipeline, aiming for ₹20,000-22,000 crore in sales in FY26, driven by robust demand in both residential and commercial sectors

Wockhardt exits US generics biz, to focus on innovative portfolio

Wockhardt exits the US generics market after years of losses, shifting focus to new antibiotic drug discovery and biologicals, including insulin, to create long-term value.

HNI, NRI demand drives 85% growth in luxury housing sales in H1 2025

Luxury housing sales grew 85% year-on-year in the first half of 2025, driven by rising demand from HNIs and NRIs seeking asset stability amid global uncertainty

Illinois Tech's Mumbai campus aims for 300-student inaugural batch in 2026

India campus tuition fee may be a third of US campus fee

GMP, NSQ compliance: MSME pharmaceutical companies seek financial aid

Pharma MSMEs seek Rs 50 crore handholding and extension for GMP compliance under revised Schedule M, citing challenges in adhering to regulatory and quality standards

Realty market saw land deals worth ₹31,000 cr in H1 2025: Anarock

Highest-ever land deal figure comes on the back of increased interest in diversified asset classes

HC-ordered expert panel for weight loss drug may be set up by mid-July

A Delhi HC directive to examine unregulated use of weight loss drugs may lead to a CDSCO expert panel by mid-July, possibly led by DCGI with pharma and govt representation

Life for Indian students in Trump's America gets increasingly tougher

Indian students putting the American dream on hold